Companies

AI × Drug Discovery Companies

47 companies applying AI to the drug discovery process, grouped by stage. Every entry has verified AI-tooling signals — public pipelines, disclosed platforms, or named collaborations — before inclusion.

Companies tracked

18 / 26

Public / Private

Disclosed programs

Public

18 companies · Listed biotechs with AI-enabled pipelines

AbCellera BiologicsCanada2▪Absci CorporationUSA1▪AC ImmuneSwitzerland4▪Alnylam PharmaceuticalsUSA6▪ArvinasUSA4▪BenevolentAIUK1▪BioNTechGermany5▪Daiichi SankyoJapan5▪Evotec SEGermany2▪Intellia TherapeuticsUSA3▪Legend BiotechChina (R&D)4▪ModernaUSA5▪Recursion PharmaceuticalsUSA4▪Relay TherapeuticsUSA2▪SchrödingerUSA1▪SOPHiA GENETICSSwitzerland Vertex PharmaceuticalsUSA4▪XtalPiUSA

Series D+

4 companies · Late-stage private companies

Insilico MedicineUSA4▪InsitroUSA OwkinUSA Valo HealthUSA1▪

Series C

3 companies · Expansion-stage AI biotechs

Arrakis TherapeuticsUSA Generate:BiomedicinesUSA1▪Numab TherapeuticsSwitzerland3▪

Series B

10 companies · Growth-stage AI biotechs

ArzedaUSA AsimovUSA AtomwiseUSA BigHat BiosciencesUSA Enveda BiosciencesUSA1▪Genesis TherapeuticsUSA1▪HealxUK1▪Iambic TherapeuticsUSA1▪Terray TherapeuticsUSA Verge GenomicsUSA1▪

Series A

6 companies · Early commercial-stage AI biotechs

AqemiaFrance Chai DiscoveryUSA Cradle BioSwitzerland Dyno TherapeuticsUSA Enable MedicineUSA Profluent BioUSA

Seed

3 companies · Seed-stage AI biotech specialists

EvolutionaryScaleUSA Latent LabsUK Manas AIUnited States (HQ not publicly fixed)

Subsidiaries

3 companies · AI-drug-discovery arms of larger entities

ExscientiaUK (now subsidiary of Recursion)3▪Isomorphic LabsUK2▪RayzeBioUSA3▪